Phase 4 Thyroid Cancer Trial, Recruiting (NCT06195228)

Phase 4 Thyroid Cancer Trial, Recruiting NCT06195228 Sponsor: Fudan University Condition: Thyroid Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06195228 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Thyroid Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are willing to take part and have signed a consent form agreeing to participate
You are within the age range accepted at the participating clinic (regardless of gender)
You have been diagnosed with locally advanced, recurrent, or spread (metastatic) thyroid cancer that cannot be fully removed by surgery, AND your cancer falls into one of these groups:
- Differentiated thyroid cancer that no longer responds to radioiodine (radioactive iodine) treatment
- Differentiated thyroid cancer that is not suitable for radioiodine treatment
- Medullary thyroid cancer
- Poorly differentiated thyroid cancer or anaplastic (fast-growing) thyroid cancer
You have had genetic testing done on your thyroid cancer before joining the trial, to look for specific gene changes related to the disease or its treatment

Who may not be able to join:

You are currently taking part in another clinical drug trial
You are pregnant or breastfeeding
There are other reasons that the trial team decides make participation unsuitable for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Dongmei Ji, M.D, Fudan University

Phone: 021-64175590

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06195228

Sponsor: Fudan University

Phase: Phase 4

Status: Recruiting

Condition: Thyroid Cancer

Trial contact: 021-64175590

More information: https://clinicaltrials.gov/study/NCT06195228

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are willing to take part and have signed a consent form agreeing to participate
You are within the age range accepted at the participating clinic (regardless of gender)
You have been diagnosed with locally advanced, recurrent, or spread (metastatic) thyroid cancer that cannot be fully removed by surgery, AND your cancer falls into one of these groups:
- Differentiated thyroid cancer that no longer responds to radioiodine (radioactive iodine) treatment
- Differentiated thyroid cancer that is not suitable for radioiodine treatment
- Medullary thyroid cancer
- Poorly differentiated thyroid cancer or anaplastic (fast-growing) thyroid cancer
You have had genetic testing done on your thyroid cancer before joining the trial, to look for specific gene changes related to the disease or its treatment

Who may not be able to join:

You are currently taking part in another clinical drug trial
You are pregnant or breastfeeding
There are other reasons that the trial team decides make participation unsuitable for you (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Fudan University

Registry

ClinicalTrials.gov

Start date

1 January 2020

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective Response Rate(ORR)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov